Search - tctmd.com

Displaying 481 - 500 of 566

Sort: Relevancy | Date

Presentation TCT 2014

How and When to Migrate Percutaneous Devices to VADs and Issues of Termination

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, Nir Uriel

September 13, 2014

Presentation TCT 2014

The Subclavian Artery Approach for ECMO

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt

September 13, 2014

Presentation TCT 2014

The Reitan Catheter Pump

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, Oyvind Reitan

September 13, 2014

Presentation TCT 2014

The Thoratec PHP

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, David E. Kandzari

September 13, 2014

Presentation TCT 2014

Impella RP: Hemodynamic Support for the Failing Right Ventricle

Presenter: Vladimir Dzavik, David R. Holmes Jr., Hiroo Takayama, Kirk N. Garratt, Ronan Margey

September 13, 2014

Presentation TCT 2014

How I Treated My Patient

Presenter: Srihari S. Naidu

September 13, 2014

Presentation TCT 2014

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Presenter: David X. Zhao

September 13, 2014

Presentation TCT 2014

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Presenter: Antonio Colombo

September 13, 2014

Presentation TCT 2014

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

Presenter: Srihari S. Naidu

September 13, 2014

Presentation TCT 2014

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jonghanne Park

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Aly El Banayosy

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) TandemHeart

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, David X. Zhao

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) Impella

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Cindy L. Grines

September 13, 2014

Presentation TCT 2014

Cardiogenic Shock: Dissecting the Data for (or Against) IABP

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Gert Richardt

September 13, 2014

Presentation TCT 2014

Overview and Comparative Analysis of Percutaneous Hemodynamic Support Devices

Presenter: Brij Maini, Holger Thiele, Rajesh M. Dave, Jeffrey W. Moses

September 13, 2014

Presentation Fellows 2014

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish Parikh

April 13, 2014

Presentation Fellows 2014

High-Risk PCI and Cardiogenic Shock: The Role of Hemodynamic Support

Presenter: Ajay Kirtane

April 13, 2014

Presentation CTO 2014

When is Hemodynamic Support Needed for Left Main PCI and Which Method?

Presenter: Jeffrey W. Moses

March 01, 2014

Presentation Advances in Hemodynamic Support 2014

When LVAD is not Enough: Migration to Biventricular Support, Adding ECMO to PVAD

Presenter: Nir Uriel

January 23, 2014

Presentation Advances in Hemodynamic Support 2014

Update on Impella Data with Cardiogenic Shock

Presenter: Jeffrey W. Moses

January 23, 2014

Advertisement

How and When to Migrate Percutaneous Devices to VADs and Issues of Termination

The Subclavian Artery Approach for ECMO

The Reitan Catheter Pump

The Thoratec PHP

Impella RP: Hemodynamic Support for the Failing Right Ventricle

How I Treated My Patient

Put Your Ego Aside: Prophylactic Use Avoids Procedural Catastrophes and Improves Late Outcomes and Should be Used in This Case!

Prophylactic Hemodynamic Support is Expensive, Causes Complications, and Is Rarely Required in High-Risk PCI. Not in This Case!

Case Presentation Setting the Stage: Should Prophylactic Hemodynamic Support Be Used?

TCT 65: The Efficacy and Safety of Mechanical Hemodynamic Support in Patients Undergoing High-Risk Percutaneous Coronary Intervention With or Without Cardiogenic Shock: Bayesian Approach Network Meta-analysis of 13 Randomized Controlled Trials

Cardiogenic Shock: Dissecting the Data for (or Against) VA ECMO

Cardiogenic Shock: Dissecting the Data for (or Against) TandemHeart

Cardiogenic Shock: Dissecting the Data for (or Against) Impella

Cardiogenic Shock: Dissecting the Data for (or Against) IABP

Overview and Comparative Analysis of Percutaneous Hemodynamic Support Devices

Thrombectomy, Embolic Protection Systems, and SVG Intervention

High-Risk PCI and Cardiogenic Shock: The Role of Hemodynamic Support

When is Hemodynamic Support Needed for Left Main PCI and Which Method?

When LVAD is not Enough: Migration to Biventricular Support, Adding ECMO to PVAD

Update on Impella Data with Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content